Bacil Pharma Ltd.
| BSE: 524516 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE711D01018 |
| BSE 00:00 | 30 Jun | 6.00 |
0.12 (2.04%) |
OPEN
5.89 |
HIGH
6.00 |
LOW
5.89 |
| NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
| OPEN | 5.89 |
| PREVIOUS CLOSE | 5.88 |
| VOLUME | 101 |
| 52-Week high | 9.55 |
| 52-Week low | 3.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bacil Pharma Ltd. (BACILPHARMA) - Announcements
-
Bacil Pharma Ltd Closure of Trading Window
30/06/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
31/05/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Non-Applicability Regulation 23(9) Disclosure Related Party Transactions For The March Quarter And Y
30/05/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Submission Of Audited Financial Results For The Quarter And Year Ended 31.03.2022
30/05/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Board Meeting Outcome for Board Meeting Outcome For Submission Of Outcome And Audited Financial Resu
30/05/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Board Meeting Intimation for Approval Of Audited Financial For The Quarter And Year Ended 31St March
21/05/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Submission Of Certificate As Per Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requir
15/04/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate
14/04/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
14/04/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Reg. 7(3) -Compliance Certificate For The Year Ended 31St March 2022
13/04/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
15/02/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
14/02/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Financial Results For Quarter Ended December 31 2021<BR>
14/02/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Board Meeting Outcome for Outcome Of Board Meeting
14/02/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Board Meeting Intimation for Approval Of Un-Audited Finanical Results For The Quarter Ended 31St Dec
04/02/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Shareholding for the Period Ended December 31 2021
20/01/2022 | bse
-
Bacil Pharma Ltd Statement Of Investor Complaints For The Quarter Ended December 2021
19/01/2022 | bse
-
Bacil Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
19/01/2022 | bse |
Downlaod PDF -
Bacil Pharma Ltd Closure of Trading Window
31/12/2021 | bse |
Downlaod PDF
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
